SCHEMBL3848490

SCHEMBL3848490

Cc1ccc(ONOc2ccc(C)cc2C23CC4CC(CC(C4)C2)C3)c(C23CC4CC(CC(C4)C2)C3)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC11 Q96DB2 4/20 0.39
HDAC2 Q92769 1/20 0.39
CASP1 P29466 1/20 0.39
CASP3 P42574 1/20 0.39
CASP7 P55210 1/20 0.39
CASP6 P55212 1/20 0.39
CASP8 Q14790 1/20 0.39
RARA P10276 3/20 0.39
RARB P10826 3/20 0.39
RARG P13631 3/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
NR1I2 O75469 1/20 0.39
LMNA P02545 1/20 0.39
PGR P06401 1/20 0.39
HSPD1 P10809 1/20 0.39
GOT1 P17174 1/20 0.39
GLRA1 P23415 1/20 0.39
BLM P54132 1/20 0.39
HSPE1 P61604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10014917 0.84 RARA (0.52) HDAC11HDAC2RARARARBRARG
SCHEMBL3855891 0.81 HDAC11 (0.37) HDAC11HDAC2RARARARBRARG
SCHEMBL23120117 0.78 RARA (0.44) HDAC11HDAC2CASP1CASP3CASP7
SCHEMBL566750 0.76 CASP1 (0.40) HDAC11HDAC2CASP1CASP3CASP7
SCHEMBL436587 0.75 KMT2A (0.42) HDAC11HDAC2CASP1CASP3CASP7
SCHEMBL396121 0.73 MEN1 (0.51) HDAC11HDAC2RARARARBRARG
SCHEMBL16397632 0.72 PDE4B (0.39) HDAC11HDAC2CASP1CASP3CASP7
SCHEMBL29869357 0.72 RARB (0.69) HDAC11HDAC2RARARARBRARG
SCHEMBL13550931 0.72 RARB (0.69) HDAC11HDAC2RARARARBRARG
SCHEMBL11702433 0.70 CNR2 (0.51) RARARARBRARGKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149555-A1 METHOD FOR PREPARING POLYHYDROXYALKANOATES, POLYMERS THUS OBTAINED, COMPOSITIONS COMPRISING THEM AND THEIR USES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149555-A1 METHOD FOR PREPARING POLYHYDROXYALKANOATES, POLYMERS THUS OBTAINED, COMPOSITIONS COMPRISING THEM AND THEIR USES HACL2, DECR1, MGLL HDAC11 3087/4885HDAC2 3991/4885CASP1 3706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.